| Hormone Replacement Therapy and Prothrombotic Variants (NCT00049933) | University of Washington | 2002-09-01 |
| Genetic Epidemiology of Blood Pressure Intervention (NCT00079690) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-09-01 |
| Novel Approaches in Linkage Analysis for Complex Traits (NCT00049855) | Mayo Clinic | 2002-09-01 |
| Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance (NCT00241072) | Novartis | 2002-09-01 |
| Cardiac and Renal Disease Study (CARDS) (NCT00049907) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-09-01 |
| Conditioned Placebo Effects and Treatment of Hypertension (NCT00269269) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-09-01 |
| Nitric Oxide and the Autonomic Nervous System (NCT00178919) | Vanderbilt University | 2002-08-01 |
| Angiotensin II Antagonism of TGF-Beta 1 (NCT00320970) | Providence Health & Services | 2002-08-01 |
| Treatment of Pediatric Hypertension With Altace Trial (NCT00044265) | Pfizer | 2002-07-01 |
| 307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects (NCT00255502) | AstraZeneca | 2002-07-01 |
| Guideline Adherence for Heart Health (NCT00224848) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-07-01 |
| Clinical Trial of Dietary Protein and Blood Pressure (NCT00046566) | Tulane University | 2002-07-01 |
| Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects (NCT00255528) | AstraZeneca | 2002-07-01 |
| Home Blood Pressure Monitoring and Blood Pressure Control (NCT00202137) | Queen's University | 2002-07-01 |
| PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM) (NCT00274638) | Boehringer Ingelheim | 2002-07-01 |
| Atrial Fibrillation Incidence, Risk Factors and Genetics (NCT00021905) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-07-01 |
| Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension (NCT00529750) | Sanofi | 2002-07-01 |
| Biological CVD Risk Factors in Older Depressed Patients (NCT00318864) | Stanford University | 2002-06-01 |
| Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension (NCT02238275) | Boehringer Ingelheim | 2002-06-01 |
| Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study (NCT00041444) | University of Wisconsin, Madison | 2002-06-01 |
| A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate Hypertension (NCT00200421) | Mylan Bertek Pharmaceuticals | 2002-05-01 |
| OmniHeart Trial: Macronutrients and Cardiovascular Risk (NCT00051350) | Johns Hopkins University | 2002-05-01 |
| Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302) (NCT00092209) | Organon and Co | 2002-04-01 |
| Effect of a Community-based Nursing Intervention on Mortality in Chronically Ill Older Adults (NCT01071967) | Health Quality Partners | 2002-04-01 |
| A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive Patients (NCT00200499) | Mylan Bertek Pharmaceuticals | 2002-03-01 |
| Study to Lower Veterans BP: Patient/Physician Intervention (NCT00105716) | US Department of Veterans Affairs | 2002-03-01 |
| ACE Inhibition and Novel Cardiovascular Risk Factors (NCT00051389) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-02-01 |
| Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives (NCT00679653) | Abbott | 2002-02-01 |
| Study on Impact of Patient-Held Guidelines on Blood Pressure (NCT00148434) | Ashgrove Research Practice | 2002-01-01 |
| Improving Medication Use in Patients With Hypertension (NCT00388817) | University of North Carolina | 2002-01-01 |
| D2 Dopamine Receptor on Human Aldosterone-Producing Adenoma and Its Role in Aldosterone Secretion and Cell Proliferation (NCT00173446) | National Taiwan University Hospital | 2002-01-01 |
| Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin (NCT00385931) | Novartis | 2002-01-01 |
| A Morbidity-Mortality and Remodeling Study With Valsartan (NCT00133328) | Jikei University School of Medicine | 2002-01-01 |
| Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus (NCT00367978) | Novartis | 2001-12-01 |
| Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism (NCT00274144) | Boehringer Ingelheim | 2001-12-01 |
| Abdominal Aortic Aneurysms and Pseudoexfoliation Syndrome (NCT00546013) | European Georges Pompidou Hospital | 2001-12-01 |
| Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension (NCT00145236) | Mylan Bertek Pharmaceuticals | 2001-11-01 |
| Interactive Multirisk-Factor Intervention for Hypertension (HTN) Blacks (NCT00207194) | Boston Medical Center | 2001-10-01 |
| The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity) (NCT00045981) | Synvista Therapeutics, Inc | 2001-10-01 |
| Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose (NCT00034840) | Boehringer Ingelheim | 2001-10-01 |
| Behavioural Treatment of Hypertension (NCT00247910) | University of British Columbia | 2001-10-01 |
| Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring (NCT02242318) | Boehringer Ingelheim | 2001-09-01 |
| Patient-Physician Partnership to Improve High Blood Pressure Adherence (NCT00123045) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-09-01 |
| Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients (NCT00125463) | The Japanese Society of Hypertension | 2001-09-01 |
| Prenatal Nutrition and Adult Disease (NCT00024583) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-09-01 |
| VA HDL Intervention Trial (VA-HIT) Ancillary Study Data Analysis (NCT00035711) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-09-01 |
| A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients (NCT00200460) | Mylan Bertek Pharmaceuticals | 2001-09-01 |
| Stepped Intervention for Meds Adherence and Blood Pressure Control (NCT00257101) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-09-01 |
| Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations Peoples (NCT00741702) | Sunnybrook Health Sciences Centre | 2001-09-01 |
| A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients (NCT00200473) | Mylan Bertek Pharmaceuticals | 2001-09-01 |
| HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED) (NCT00480805) | Organon and Co | 2001-08-08 |
| The Double Exposure Study: The Impact of Job Strain and Marital Cohesion on Blood Pressure (NCT00133653) | Sunnybrook Health Sciences Centre | 2001-08-01 |
| A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas (NCT00846300) | The University of Texas Health Science Center at San Antonio | 2001-08-01 |
| The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling (NCT00045994) | Synvista Therapeutics, Inc | 2001-08-01 |
| Mechanisms and Therapeutic Effects of the Relaxation Response in Elderly Hypertensive Patients (NCT00179543) | Beth Israel Deaconess Medical Center | 2001-08-01 |
| Health Assessment Study (0954-946) (NCT00541684) | Organon and Co | 2001-07-11 |
| Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure (NCT02242331) | Boehringer Ingelheim | 2001-06-01 |
| Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension (NCT00060918) | GlaxoSmithKline | 2001-06-01 |
| Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension (NCT00060931) | GlaxoSmithKline | 2001-06-01 |
| Progression Evaluation and Genetic Determinants of Hypertension in Chinese - A Follow-up Study of Taiwan SAPPHIRe (NCT00260910) | National Health Research Institutes, Taiwan | 2001-05-01 |
| The Effect of North American Ginseng on Blood Pressure in Individuals With Hypertension (NCT00219960) | Risk Factor Modification Centre | 2001-04-01 |
| Walking Intervention in African American Adults With Newly Diagnosed Hypertension (NCT00298207) | University of Illinois at Chicago | 2001-04-01 |
| Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNT (NCT00021918) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-04-01 |
| New CVD Risk Factors for Lowered Cognitive Functioning (NCT00037310) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-04-01 |
| SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients (NCT00274105) | Boehringer Ingelheim | 2001-03-01 |
| Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients (NCT00018759) | US Department of Veterans Affairs | 2001-03-01 |
| Cardiovascular Phenotype Study in Patients With Obstructive Sleep Apnea Syndrome (NCT00764218) | University Hospital, Grenoble | 2001-03-01 |
| A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension (NCT00236665) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-03-01 |
| Dose-Response to Exercise in Women Aged 45-75 Years (DREW) (NCT00011193) | Pennington Biomedical Research Center | 2001-01-01 |
| Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension (NCT02202525) | Boehringer Ingelheim | 2001-01-01 |
| Treatment of Supine Hypertension in Autonomic Failure (NCT00223717) | Vanderbilt University | 2001-01-01 |
| Danish Hypertension Prevention Project - DHYPP (NCT00150631) | Karin Skov | 2000-11-01 |
| Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension (NCT02245464) | Boehringer Ingelheim | 2000-11-01 |
| The Hypertension in the Very Elderly Trial (HYVET) (NCT00122811) | Imperial College London | 2000-11-01 |
| To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg (NCT00946725) | Sandoz | 2000-11-01 |
| Effects of a Comprehensive Intervention on Blood Pressure Control in a Primary Care Setting (NCT01915199) | Finnish Institute for Health and Welfare | 2000-10-01 |
| The Jackson Heart Study of Cardiovascular Disease Among African Americans (NCT00005485) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-09-19 |
| Improving Quality With Outpatient Decision Support (NCT00225628) | Agency for Healthcare Research and Quality (AHRQ) | 2000-09-01 |
| Analyzing How Genetics May Affect Response to High Blood Pressure Medications (NCT00563901) | University of Alabama at Birmingham | 2000-09-01 |
| Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood Pressure (NCT00115726) | University of Calgary | 2000-09-01 |
| Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis (NCT02178306) | Boehringer Ingelheim | 2000-09-01 |
| Hypertension in Black Americans: A Life Course Approach (NCT00006408) | Duke University | 2000-08-01 |
| Amino Acids in Urine, Diet, and Blood Pressure: International Population Study (NCT00006406) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-08-01 |
| Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension (NCT02206659) | Boehringer Ingelheim | 2000-08-01 |
| Genetics of Coronary Artery Disease in Alaskan Natives (GOCADAN) (NCT00006192) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-08-01 |
| Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension (NCT02269176) | Boehringer Ingelheim | 2000-07-01 |
| Effects of Rosiglitazone on Blood Vessels in Patients With High Blood Pressure and High Cholesterol (NCT00006071) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-07-01 |
| Blood Pressure Control in Juveniles - Longitudinal Study (NCT00005181) | Indiana University | 2000-07-01 |
| Genetics of Hypertension and Its Intermediate Phenotypes (NCT00006499) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-06-01 |
| Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals (NCT02238262) | Boehringer Ingelheim | 2000-05-01 |
| A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM) (NCT02200653) | Boehringer Ingelheim | 2000-05-01 |
| Measuring Blood Pressure in Pregnancy Using Mercury and Automated Device (NCT00809666) | St George Hospital, Australia | 2000-05-01 |
| Heart Disease on the Mend (NCT00127751) | Stanford University | 2000-05-01 |
| To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet Under Fasting and Fed (NCT00883506) | Sandoz | 2000-05-01 |
| Ramipril - Hypertension (NCT00325806) | Sanofi | 2000-05-01 |
| Hypertension Control Based on Home Blood Pressure (NCT00198562) | Ministry of Health, Labour and Welfare, Japan | 2000-04-01 |
| Telmisartan Compared With Enalapril in Elderly Patients With Blood Hypertension (NCT02177461) | Boehringer Ingelheim | 2000-04-01 |
| Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy (NCT00295542) | University of Vigo | 2000-03-01 |
| Telmisartan in Mild to Moderate Hypertensive Patients (NCT02260089) | Boehringer Ingelheim | 2000-03-01 |
| To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablets Under Fasting Conditions (NCT00883064) | Sandoz | 2000-03-01 |